36
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Acute phase response and oxidative stress status in familial Mediterranean fever (FMF)

, , , , , & show all
Pages 431-437 | Received 25 May 2011, Accepted 16 Aug 2011, Published online: 02 Jan 2014

References

  • Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53.
  • Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore). 1998;77: 268–97.
  • Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. Oxford: Clarendon Press; 2007.
  • Onen F. Familial Mediterranean fever. Rheumatol Int. 2006;26: 489–96.
  • Simon A, van der Meer JW. Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes. Am J Physiol Regul Integr Comp Physiol. 2007;292:86–98.
  • Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res. 2004;567:1–61.
  • Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–85.
  • Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302–10.
  • Gorog P, Kotak DC, Kovacs IB. Simple and specific test for measuring lipid peroxides in plasma. J Clin Pathol. 1991;44: 765–7.
  • Slater TF. Overview of methods used for detecting lipid peroxi-dation. Methods Enzymol. 1984;105:283–93.
  • Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxi-dant protection against hypochlorous acid in human plasma. J Lab Clin Med. 1993;121:257–62.
  • Reznick AZ, Packer L. Oxidative damage to proteins: spectro-photometric method for carbonyl assay. Methods Enzymol. 1994;233:357–63.
  • Beutler E, Duron E, Kelly BM. Improved method for the deter-mination of blood glutathione. J Lab Clin Med. 1963;61:882–8.
  • Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497–500.
  • Paglia DE, Valentine WN. Studies on the quantitative and qual-itative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–69.
  • Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991;196:143–51.
  • Mannaerts GP, Van Veldhoven PP, Casteels M. Peroxisomal lipid degradation via beta and alpha-oxidation in mammals. Cell Biochem Biophys. 2000;32:73–87.
  • Manda G, Nechifo MT, Neagu TM. Reactive oxygen species, cancer and anti-cancer therapies. Curr Chem Biol. 2009;3: 342–66.
  • Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stohs SJ. The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol. 2001;21:69–73.
  • Seven A, Giizel S, Aslan M, Hamuryudan V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin Biochem. 2008;41(7-8):538–43.
  • Sarkisian T, Emerit I, Arutyunyan R, Levy A, Cernjavski L, Filipe P. Familial Mediterranean fever: clastogenic plasma fac-tors correlated with increased 02(-)-production by neutrophils. Hum Genet. 1997;101:238–42.
  • Keskin G, Inal A, Sengiil A, Cindoruk M, Haznedaroglu S, Duranay M, et al. Phagocytic activity in familial Mediterranean fever. Yonsei Med J. 2000;41:441–4.
  • Emerit I, Arutyunyan R, Sarkisian T, Mejlumian H, Torosian E, Panossian AG. Oxyradical-mediated chromosome damage in patients with familial Mediterranean fever. Free Radic Biol Med. 1993;15:265–71.
  • Bagci S, Toy B, Tuzun A, Ates Y, Aslan M, Inal A, et al. Con-tinuity of cytokine activation in patients with familial Mediter-ranean fever. Clin Rheumatol. 2004;23:333–7.
  • International Commitee for Standardization in Haematology. Guidelines on Selection of Laboratory Test for monitoring the acute phase response. J Clin Pathol. 1988;41:1203–12.
  • Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol. 2003;22:99–101.
  • Tunca M, Kirkali G, Soyturk M, Akar S, Pepys MB, Hawkins PN. Acute phase response and evolution of familial Mediterranean fever. Lancet. 1999;353:1415.
  • Lachmann HJ, Sengiil B, Yavumen TU, Booth DR, Booth SE, Bybee A, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746–50.
  • Korkmaz C, Ozdogan H, Kasamopur 0, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis. 2002;61:79–81.
  • Yazici H, Ozdogan H. Familial Mediterranean fever in Turkey. In: Sohar E, Gafni J, Pras M. editors. I International Conference on FMF. London: Freund Publishing House; 1997. p. 66–71.
  • Antolovich M, Prenzler PD, Patsalides E, McDonald S, Robards K. Methods for testing antioxidant activity. Analyst. 2002;127: 183–98.
  • Chaturvedi V, Handa R, Rao DN, Wali JP. Estimation and sig-nificance of serum and synovial fluid malondialdehyde levels in rheumatoid arthritis. Indian J Med Res. 1999;109:170–4.
  • Kirkali G, Tunca M, Gene S, Jaruga P, Dizdaroglu M. Oxidative DNA damage in polymorphonuclear leukocytes of patients with familial Mediterranean fever. Free Radic Biol Med. 2008;44: 386–93.
  • Gurbuz M, Yamanel L, Bulucu F, Inal V, Aydin A. Oxidative stress status in familial Mediterranean fever with or without proteinuria. Free Radic Biol Med. 2005;38:271–5.
  • Seven A, Giizel S, Asian M, Hamuryudan V. Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int. 2009;29(7):743–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.